Izotropic Engages International Communications Consultant, Grants Incentive Stock Options & RSUs to Key Personnel, Amends Promissory Note with Primary Lender
Izotropic (IZOZF) has announced several key corporate updates. The company has engaged JG Global Communications as its International Communications Consultant for a 6-month term at $6,000 monthly, with the consultant receiving 200,000 stock options at $0.31 and 200,000 RSUs.
The company granted additional equity awards totaling 3,000,000 stock options at CAD $0.31 and 300,000 RSUs to directors, officers, and consultants.
Additionally, Izotropic amended its loan agreement with 0914474 BC The loan balance has increased to CAD $2,675,000, reflecting accrued interest and extension fees. The loan carries a 12% annual interest rate, payable quarterly, with the next maturity date set for September 30, 2025. As part of the amendment, 3,000,000 bonus warrants were issued at $0.31 per share with a 5-year term.
Izotropic (IZOZF) ha annunciato diversi aggiornamenti aziendali chiave. L'azienda ha ingaggiato JG Global Communications come suo consulente per le comunicazioni internazionali per un periodo di 6 mesi al costo di $6,000 mensili, con il consulente che riceverà 200,000 opzioni su azioni a $0.31 e 200,000 RSU.
L'azienda ha concesso ulteriori premi azionari per un totale di 3,000,000 opzioni su azioni a CAD $0.31 e 300,000 RSU a direttori, funzionari e consulenti.
Inoltre, Izotropic ha modificato il suo accordo di prestito con 0914474 BC. Il saldo del prestito è aumentato a CAD $2,675,000, riflettendo gli interessi accumulati e le spese di estensione. Il prestito ha un tasso d'interesse annuale del 12%, pagabile trimestralmente, con la prossima scadenza fissata per il 30 settembre 2025. Come parte della modifica, sono state emesse 3,000,000 opzioni bonus a $0.31 per azione con un termine di 5 anni.
Izotropic (IZOZF) ha anunciado varias actualizaciones corporativas clave. La compañía ha contratado a JG Global Communications como su Consultor de Comunicaciones Internacionales por un período de 6 meses a $6,000 mensuales, recibiendo el consultor 200,000 opciones sobre acciones a $0.31 y 200,000 RSUs.
La compañía otorgó premios adicionales en acciones por un total de 3,000,000 opciones sobre acciones a CAD $0.31 y 300,000 RSUs a directores, funcionarios y consultores.
Además, Izotropic modificó su acuerdo de préstamo con 0914474 BC. El saldo del préstamo ha aumentado a CAD $2,675,000, reflejando los intereses acumulados y las tarifas de extensión. El préstamo tiene una tasa de interés anual del 12%, pagadera trimestralmente, con la próxima fecha de vencimiento fijada para el 30 de septiembre de 2025. Como parte de la modificación, se emitieron 3,000,000 garantías de bonificación a $0.31 por acción con un plazo de 5 años.
Izotropic (IZOZF)는 몇 가지 주요 기업 업데이트를 발표했습니다. 회사는 JG Global Communications를 6개월 동안 월 $6,000에 국제 커뮤니케이션 컨설턴트로 고용했으며, 컨설턴트는 $0.31에 200,000주식 옵션과 200,000 RSU를 받게 됩니다.
회사는 이사, 임원 및 컨설턴트에게 CAD $0.31에 3,000,000주식 옵션과 300,000 RSU의 추가 주식 보상을 부여했습니다.
또한, Izotropic은 0914474 BC와의 대출 계약을 수정했습니다. 대출 잔액은 이자와 연장 수수료가 누적되어 CAD $2,675,000로 증가했습니다. 대출은 연 12%의 이자율이 적용되며, 분기마다 지급되며, 다음 만기일은 2025년 9월 30일로 설정되어 있습니다. 수정의 일환으로, $0.31에 3,000,000개의 보너스 워런트가 5년 만기로 발행되었습니다.
Izotropic (IZOZF) a annoncé plusieurs mises à jour clés de l'entreprise. La société a engagé JG Global Communications en tant que consultant en communications internationales pour une durée de 6 mois à 6 000 $ par mois, le consultant recevant 200 000 options d'achat d'actions à 0,31 $ et 200 000 RSU.
La société a accordé des récompenses en actions supplémentaires totalisant 3 000 000 options d'achat d'actions à 0,31 CAD et 300 000 RSU à des directeurs, des dirigeants et des consultants.
De plus, Izotropic a modifié son contrat de prêt avec 0914474 BC. Le solde du prêt a augmenté à 2 675 000 CAD, reflétant les intérêts accumulés et les frais d'extension. Le prêt a un taux d'intérêt annuel de 12 %, payable trimestriellement, avec la prochaine date d'échéance fixée au 30 septembre 2025. Dans le cadre de l'amendement, 3 000 000 bons de souscription ont été émis à 0,31 $ par action avec une durée de 5 ans.
Izotropic (IZOZF) hat mehrere wichtige Unternehmensaktualisierungen angekündigt. Das Unternehmen hat JG Global Communications als seinen internationalen Kommunikationsberater für einen Zeitraum von 6 Monaten zu einem Preis von 6.000 $ monatlich engagiert, wobei der Berater 200.000 Aktienoptionen zu 0,31 $ und 200.000 RSUs erhält.
Das Unternehmen hat zusätzliche Eigenkapitalvergütungen in Höhe von insgesamt 3.000.000 Aktienoptionen zu CAD 0,31 und 300.000 RSUs an Direktoren, Führungskräfte und Berater gewährt.
Darüber hinaus hat Izotropic seinen Darlehensvertrag mit 0914474 BC geändert. Der Darlehenssaldo ist auf CAD 2.675.000 gestiegen, was auf aufgelaufene Zinsen und Verlängerungsgebühren zurückzuführen ist. Das Darlehen hat einen jährlichen Zinssatz von 12%, der vierteljährlich zahlbar ist, und das nächste Fälligkeitsdatum ist auf den 30. September 2025 festgelegt. Im Rahmen der Änderung wurden 3.000.000 Bonus-Warrants zu 0,31 $ pro Aktie mit einer Laufzeit von 5 Jahren ausgegeben.
- Secured experienced international communications consultant with proven track record ($100M+ raised)
- Enhanced global market reach potential, particularly in Asia and Europe
- Consultant has significant skin in the game with 1M+ personal shareholding
- Increased debt burden with loan balance growing to CAD $2.675M from initial $2M
- High interest rate of 12% annually on the loan
- Significant equity dilution through issuance of 3.3M stock options and 300K RSUs
- Additional dilution potential from 3M bonus warrants issued to lender
Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - April 2, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing imaging-based products utilizing innovative and emerging technologies for the more accurate screening, diagnoses, and treatment of breast cancers, announces that it has engaged an International Communications Consultant, and granted Incentive Stock Options and Restricted Share Units to Directors, Advisors, and Key Consultants.
International Communications Consultant
Izotropic has engaged JG Global Communications, led by Mr. James Gagnon, to represent the Company as its International Communications Consultant.
Mr. Gagnon brings over two decades of experience in international finance and investor relations, has raised over
In the role of International Communications Consultant, JG Global Communications will lead proactive outbound investor communications and global outreach efforts on behalf of Izotropic, with a focus on increasing awareness of Izotropic's technology and value proposition; building relationships with individual investors, brokers, family offices, and healthcare-focused funds; and identifying new sources of investor interest that to impact market investment and financing activities while increasing global recognition of the Company's mission and technologies.
As a long-time shareholder of the Company, Mr. Gagnon personally holds over 1 million shares in Izotropic.
JG Global Communications has been engaged for a six (6) month term at
Incentive Stock Options and Restricted Share Units
The Company has issued additional Stock Options and Restricted Share Units to certain directors, officers, and consultants in recognition of their ongoing contributions and to align their interests with those of the Company's shareholders. These equity awards form part of the Company's long-term incentive compensation plan and are intended to support retention and continued performance among key team members.
Pursuant to the Company's Stock Option Plan, 2,800,000 stock options have been granted at an exercise price of CAD
Pursuant to the Company's Long Term Incentive Plan, 100,000 Restricted Share Units have been issued and vest immediately.
In total, 3,000,000 Stock Options and 300,000 Restricted Share Units have been issued.
Amended Promissory Note Agreement and Bonus Warrants Issuance
Izotropic Corporation has entered into an amended loan agreement (the "Amended Loan Agreement") with 0914474 BC Ltd. (the "Lender") effective March 31, 2025.
Initial Loan Summary
The original unsecured loan of
Amended Loan Details
The Company and the Lender have agreed to amend the terms of the loan. As of March 31, 2025, the new loan balance stands at
- The
$2,415,000 b alance as of June 30, 2024, - Additional accrued interest of
$180,000 for the period July 1, 2024, to March 31, 2025, - A
5% extension fee of$100,000 for the current 6-month term (July 1 - Dec 31, 2024).
The loan now carries forward in renewable 6-month terms until repaid in full. Interest continues to accrue at
New Bonus Warrants
In conjunction with the amended loan terms, the Company will issue 3,000,000 bonus warrants to the Lender, exercisable at a deemed price of
Security Agreement
The loan is secured by a General Security Agreement entered into by the Company and the Lender in September 2024, covering the principal, accrued interest, and any extension fees.
Change of Control Clause
In the event of a change in control or material change in the Company's board or management, the amended loan, interest, and any fees become immediately payable unless otherwise agreed to by the Lender.
Regulatory Approval
The Amended Loan Agreement and associated securities may be subject to approval by the Canadian Securities Exchange (CSE).
About Izotropic:
More information about Izotropic Corporation can be found on its website at izocorp.com and by reviewing its profile on SEDAR at sedarplus.ca.
Forward-Looking Statements:
This document may contain statements that are "Forward-Looking Statements," which are based upon the current estimates, assumptions, projections, and expectations of the Company's management, business, and its knowledge of the relevant market and economic environment in which it operates. The Company has tried, where possible, to identify such information and statements by using words such as "anticipate," "believe," "envision," "estimate," "expect," "intend," "may," "plan," "predict," "project," "target," "potential," "will," "would," "could," "should," "continue," "contemplate" and other similar expressions and derivations thereof in connection with any discussion of future events, trends or prospects or future operating or financial performance, although not all forward-looking statements contain these identifying words.
These statements are not guarantees of performance and involve risks, including those related to capital requirements and uncertainties that are difficult to control or predict, and as such, they may cause future results of the Company's activity to differ significantly from the content and implications of such statements. Forward-Looking Statements are pertinent only as of the date on which they are made, and the Company undertakes no obligation to update or revise any Forward-Looking Statements to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. Neither the Company nor its shareholders, officers, and consultants shall be liable for any action and the results of any action taken by any person based on the information contained herein, including, without limitation, the purchase or sale of Company securities. Nothing in this document should be deemed to be medical or other advice of any kind. All images are for illustrative purposes only. IzoView has not yet been approved or cleared for sale.
Contacts:
Izotropic Corporation
Robert Thast
Interim Chief Executive Officer
Telephone: 1-604-220-5031 or 1-800-IZOCORP ext. 3
Email: bthast@izocorp.com
General Inquiries
Telephone: 1-604-825-4778 or 1-800-IZOCORP ext. 1
Email: info@izocorp.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/247116
FAQ
What are the terms of IZOZF's amended loan agreement as of March 2025?
How many stock options and RSUs did IZOZF grant in April 2025?
What are the terms of IZOZF's engagement with JG Global Communications?
How has IZOZF's loan balance changed from the original 2022 agreement?
